Table 2.
TMS Protocols and Outcomes for STB
| Protocol Type | STB Outcomes | Response Rate | Treatment Duration |
|---|---|---|---|
| Accelerated (aTMS/TBS) | Demonstrated significant and rapid decreases to suicidality | Up to 100% response | 1–2 weeks |
| cTBS | Found to be superior to iTBS in one study for suicidality | 72.73% remission | 1 week (a-cTBS) |
| iTBS* | Found to demonstrate significant decrease in suicidality in multiple studies | 65.63 – 93.33% response | 1–2 weeks, (some a-iTBS) |
| dTMS | Found to demonstrate significant decrease in suicidality | 41.2 – 70.6% response | 4–6 weeks |
| rTMS (bilateral) | Found to be superior to sham in one study, specifically for bilateral treatment | 40.4% remission | 3–6 weeks |
| HFR rTMS * | Found to demonstrate significant decrease in suicidality in multiple studies | 64.9% - 97.5% response | 2–6 weeks |
| LFR rTMS | Found to have mixed-results and less efficacy than HFR rTMS | 55.6% | 2–4 weeks |
Note:
High Frequency rTMS targeting the left dlPFC, and iTBS protocols were found to be the most consistent and effective protocols in reducing suicidality across the included studies.